Pharmaceutical Development and Technology 2015-03-01

Formulation approaches to improving the delivery of an antiviral drug with activity against seasonal flu.

Srinivasa M Sammeta, Li Wang, Shravan K Mutyam, Kathleen O'Loughlin, Carol E Green, Milton H Werner, Terence Kelly, Gita N Shankar

Index: Pharm. Dev. Technol. 20(2) , 169-75, (2015)

Full Text: HTML

Abstract

The main objective of the present study was to develop formulations of noscapine hydrochloride hydrate with enhanced solubility and bioavailability using co-solvent- and cyclodextrin-based approaches. Different combinations of co-solvents, which were selected on the basis of high-throughput solubility screening, were subjected to in vitro intestinal drug permeability studies conducted with Ussing chambers. Vitamin E tocopherol polyethylene glycol succinate and propylene glycol based co-solvent formulations provided the maximum permeability coefficient for the drug. Inclusion complexes of the drug were prepared using hydroxypropyl-β-cyclodextrin and sulphobutylether cyclodextrins. Pharmacokinetic studies were carried out in male Sprague-Dawley rats for the selected formulations. The relative bioavailabilities of the drug with the co-solvent- and cyclodextrin-based formulations were found to be similar.

Related Compounds

Structure Name/CAS No. Articles
Glycerol Structure Glycerol
CAS:56-81-5
Sodium hydroxide Structure Sodium hydroxide
CAS:1310-73-2
Disodium hydrogenorthophosphate Structure Disodium hydrogenorthophosphate
CAS:7558-79-4
Orthoboric acid Structure Orthoboric acid
CAS:10043-35-3
Noscapine hydrochloride Structure Noscapine hydrochloride
CAS:912-60-7
potassium chloride Structure potassium chloride
CAS:7447-40-7
3-Ethyl-2,4-pentanedione Structure 3-Ethyl-2,4-pentanedione
CAS:1540-34-7
Vitamin E Structure Vitamin E
CAS:10191-41-0
Propylene Glycol Structure Propylene Glycol
CAS:57-55-6
Boric acid-11B Structure Boric acid-11B
CAS:13813-78-0